Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jinjiao He"'
Autor:
Yunzhou Wu, Jinjiao He, Ying An, Xi Wang, Yunye Liu, Shijun Yan, Xianlong Ye, Jianying Qi, Shenglong Zhu, Qingzhong Yu, Jiechao Yin, Deshan Li, Wenfei Wang
Publikováno v:
Journal of Pharmacological Sciences, Vol 132, Iss 1, Pp 24-30 (2016)
Newcastle disease virus (NDV) have shown oncolytic therapeutic efficacy in preclinical study and are currently approved for clinical trials. NDV Anhinga strain which is a mesogenic strain should be classified as lytic strain and has a therapeutic eff
Externí odkaz:
https://doaj.org/article/af89f03aea424efaad69ea00064b22e3
Autor:
Ziye Pan, Jinjiao He, Lubna M Rasoul, Yunye Liu, Ruixiang Che, Yun Ding, Xiaocheng Guo, Jiarui Yang, Dehua Zou, Hua Zhang, Deshan Li, Hongwei Cao
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0171400 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0164723.].
Externí odkaz:
https://doaj.org/article/e2c0b1a48c024774929df01bc187a256
Autor:
Ziye Pan, Jinjiao He, Lubna M Rasoul, Yunye Liu, Ruixiang Che, Yun Ding, Xiaocheng Guo, Jiarui Yang, Dehua Zou, Hua Zhang, Deshan Li, Hongwei Cao
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164723 (2016)
Recombinant Newcastle disease virus (rNDV) is tumor selective and intrinsically oncolytic, which has been developed as a vector to express exogenous genes to enhance its oncolytic efficacy. Our previous studies found that insertion sites of foreign g
Externí odkaz:
https://doaj.org/article/6b72621d978d4ae3b28b886b031c31e2
Autor:
Qingzhong Yu, Lin Cui, Ying An, Jianying Qi, Yunzhou Wu, Jiechao Yin, Jinjiao He, Kai Yang, Xiaohui Jing, Mingyao Liu, Hui Dong, Bo Qu, Shijun Yan, Deshan Li
Publikováno v:
Journal of Medical Virology. 93:3890-3898
Oncolytic virus therapy is perhaps the next major breakthrough in cancer treatment following the success in immunotherapy using immune checkpoint inhibitors. However, the potential oncolytic ability of the recombinant newcastle disease virus (NDV) An
Publikováno v:
ChemCatChem. 11:6324-6331
KGaA, Weinheim Three metal-salen (Ni, Cu, Zn) complexes were firstly introduced into homogeneous photocatalytic hydrogen-evolution systems. Based on these complexes, we developed noble-metal-free hydrogen production systems using disodium salts of Eo
Publikováno v:
Current Pharmaceutical Analysis. 15:333-337
Background:Erythropoietin is a highly glycosylated protein hormone, used medically for the treatment of anemia associated with chronic renal disease. Due to patent expirations, we expect biosimilar erythropoietins to play an increasing role in health
Autor:
Pengfei Xu, Xiaohui Ma, Jinjiao He, Yingjie Zhang, Jian Li, Deshan Li, Jun-yan Li, Mir Hassan Khoso, Xinghao Jiang, Liying Song, Guiping Ren
Publikováno v:
Biomedicine & Pharmacotherapy. 84:97-105
The aim of this study is to explore a new method-high dose starting and low dose maintaining for PEGylated Fibroblast growth factor 21 (pFGF-21) treatment. Db/db mice were initially treated with pFGF-21 of high dose, then treated with pFGF-21 of low
Autor:
Xin Liu, Guiyou Tian, Deshan Li, Xiaochen Guo, Lubna M. Rasoul, Ruixiang Che, Dan Yu, Liying Song, Hongsong Wu, Ying An, Pengfei Xu, Hongwei Cao, Ziye Pan, Jinjiao He, Jiechao Yin, Yunye Liu
Publikováno v:
Virus Research. 221:23-29
Newcastle disease virus (NDV) is an intrinsically tumor-specific virus, many researchers have reported that lentogenic NDV is a safe and effective agent for human cancer therapy. It had been demonstrated that the amino acid sequence of the fusion pro
Autor:
Shuang-qing Liu, Yunye Liu, Jiechao Yin, Xin Liu, Jinjiao He, Deshan Li, Guiping Ren, Guiyou Tian, Xinyu Gao, Yin-Hang Yu, Xu Zhang, Tian Sun
Publikováno v:
Technology in Cancer Research & Treatment. 15:NP83-NP94
Interleukins as immunomodulators are promising therapeutic agents for cancer therapy. Previous studies showed that there was an improved antitumor immunity in tumor-bearing mice using recombinant Newcastle disease virus carrying for interleukin-2. In
Autor:
Yunzhou Wu, Tianyan Liu, Rui Chen, Deshan Li, Jiechao Yin, Xiaochen Guo, Jinjiao He, Ying An, Yin Bai, Guiping Ren, Yunye Liu, Qi Zheng, Hongsong Wu, Chang Liu
Publikováno v:
Journal of Biomedical Science
Background Numerous studies have demonstrated that the NDV-mediated gene therapy is a promising new approach for treatment of cancers. P53 plays a vital role in tumor suppression and surveillance. Therefore, we hypothesize that a recombinant NDV expr